ArriVent BioPharma Price Target Cut to $37.55, Implies 32% Upside
A 12-month price target for ArriVent BioPharma, Inc. was reduced to $37.55, suggesting a potential 32% increase from its current trading level.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.